Literature DB >> 6416309

Neurophysiological studies of sensory gating in mania: comparison with schizophrenia.

R D Franks, L E Adler, M C Waldo, J Alpert, R Freedman.   

Abstract

The action of central nervous system mechanisms involved in sensory gating was assessed in acutely psychotic manic patients. An early positive component of the auditory average evoked response, recorded at the vertex 50 msec after a click stimulus, was studied. Stimuli were delivered at 10-sec intervals to establish a base-line response. Sensory gating mechanisms were then tested using a conditioning-testing paradigm to assess the change in response to a second stimulus following the first at either 0.5-, 1.0- or 2.0-sec intervals. A similar paradigm had been used previously to assess deficits in this function in acute and chronic schizophrenics. We found a deficit in sensory gating in acutely manic patients. similar to that found in schizophrenics, although the variability in response was more marked in the manic patients. We followed these patients during their treatment on lithium carbonate and found a return of these neuronal functions towards normal values which corresponded to their clinical improvement. A series of stable euthymic bipolar patients were found to have responses indistinguishable from normal controls. The data suggest that deficits in neuronal gating functions, similar to those found in schizophrenia, can be seen during acute mania but these deficits return to normal as the acute psychosis abates.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416309

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  24 in total

1.  Mapping repetition suppression of the N100 evoked response to the human cerebral cortex.

Authors:  Nash N Boutros; Klevest Gjini; Horst Urbach; Mark E Pflieger
Journal:  Biol Psychiatry       Date:  2011-01-28       Impact factor: 13.382

2.  The auditory P50 component to onset and offset of sound.

Authors:  Hillel Pratt; Arnold Starr; Henry J Michalewski; Naomi Bleich; Nomi Mittelman
Journal:  Clin Neurophysiol       Date:  2007-12-04       Impact factor: 3.708

3.  Towards a functional topography of sensory gating areas: invasive P50 recording and electrical stimulation mapping in epilepsy surgery candidates.

Authors:  Martin Kurthen; Peter Trautner; Timm Rosburg; Thomas Grunwald; Thomas Dietl; Kai-Uwe Kühn; Carlo Schaller; Christian E Elger; Horst Urbach; Kost Elisevich; Nash N Boutros
Journal:  Psychiatry Res       Date:  2007-05-21       Impact factor: 3.222

Review 4.  Raising attention to attention deficit hyperactivity disorder in schizophrenia.

Authors:  Stefano Pallanti; Luana Salerno
Journal:  World J Psychiatry       Date:  2015-03-22

5.  Mapping repetition suppression of the P50 evoked response to the human cerebral cortex.

Authors:  Nash N Boutros; Klevest Gjini; Simon B Eickhoff; Horst Urbach; Mark E Pflieger
Journal:  Clin Neurophysiol       Date:  2012-11-04       Impact factor: 3.708

6.  Cell loss in the hippocampus of schizophrenics.

Authors:  P Falkai; B Bogerts
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

Review 7.  Sensory gating: a translational effort from basic to clinical science.

Authors:  Howard C Cromwell; Ryan P Mears; Li Wan; Nash N Boutros
Journal:  Clin EEG Neurosci       Date:  2008-04       Impact factor: 1.843

8.  P50, N100, and P200 sensory gating: relationships with behavioral inhibition, attention, and working memory.

Authors:  Marijn Lijffijt; Scott D Lane; Stacey L Meier; Nash N Boutros; Scott Burroughs; Joel L Steinberg; F Gerard Moeller; Alan C Swann
Journal:  Psychophysiology       Date:  2009-06-08       Impact factor: 4.016

9.  Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 10.  Pre-attentive processing and schizophrenia: animal studies.

Authors:  Bart A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  2003-12-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.